Haploinsufficient Rock1+/− and Rock2+/− Mice Are Not Protected from Cardiac Inflammation and Postinflammatory Fibrosis in Experimental Autoimmune Myocarditis
Abstract
1. Introduction
2. Methods
2.1. Mice
2.2. EAM Induction
2.3. Cell Cultures
2.4. Flow Cytometry
2.5. Histology and Immunohistochemistry
2.6. Immunoblotting
2.7. Quantitative RT-PCR
2.8. Immunocytochemistry
2.9. Statistics
3. Results
3.1. Rock1+/− and Rock2+/− Haploinsufficient Mice Develop Unaffected Myocarditis
3.2. TGF-β Induces Profibrotic Changes in Cardiac Fibroblasts and in Inflammatory Myeloid Cells
3.3. ROCK1 Differentially Regulates TGF-β Downstream Molecular Pathways in Cardiac Fibroblasts and in Inflammatory Myeloid Cells
3.4. ROCK1 Enhances Profibrotic TGF-β Response in Cardiac Fibroblasts and in Inflammatory Myeloid Cells
3.5. Rock1+/− and Rock2+/− Haploinsufficient Mice Are Not Protected from Cardiac Fibrosis in EAM
4. Discussion
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Li, L.; Zhao, Q.; Kong, W. Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol. 2018, 68–69, 490–506. [Google Scholar] [CrossRef]
- Kong, P.; Christia, P.; Frangogiannis, N.G. The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 2014, 71, 549–574. [Google Scholar] [CrossRef] [PubMed]
- Bracamonte-Baran, W.; Čiháková, D. Cardiac Autoimmunity: Myocarditis. Adv. Exp. Med. Biol. 2017, 1003, 187–221. [Google Scholar] [CrossRef] [PubMed]
- D’Ambrosio, A.; Patti, G.; Manzoli, A.; Di Sciascio, G.; Sinagra, G.; Di Lenarda, A.; Silvestri, F. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: A review. Heart 2001, 85, 499–504. [Google Scholar] [CrossRef] [PubMed]
- Błyszczuk, P. Myocarditis in Humans and in Experimental Animal Models. Front. Cardiovasc. Med. 2019, 6, 64. [Google Scholar] [CrossRef]
- Kania, G.; Blyszczuk, P.; Eriksson, U. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc. Med. 2009, 19, 247–252. [Google Scholar] [CrossRef]
- Rosenkranz, S.; Flesch, M.; Amann, K.; Haeuseler, C.; Kilter, H.; Seeland, U.; Schlüter, K.D.; Böhm, M. Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1. Am. J. Physiol. Hear. Circ. Physiol. 2002, 283, 1253–1262. [Google Scholar] [CrossRef]
- Kania, G.; Blyszczuk, P.; Stein, S.; Valaperti, A.; Germano, D.; Dirnhofer, S.; Hunziker, L.; Matter, C.M.; Eriksson, U. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor β-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circ. Res. 2009, 105, 462–470. [Google Scholar] [CrossRef]
- Ma, Z.G.; Yuan, Y.P.; Wu, H.M.; Zhang, X.; Tang, Q.Z. Cardiac fibrosis: New insights into the pathogenesis. Int. J. Biol. Sci. 2018, 14, 1645–1657. [Google Scholar] [CrossRef]
- Działo, E.; Tkacz, K.; Błyszczuk, P. Crosstalk between the TGF-β and WNT signalling pathways during cardiac fibrogenesis. Acta Biochim. Pol. 2018, 65, 341–349. [Google Scholar] [CrossRef]
- Heasman, S.J.; Ridley, A.J. Mammalian Rho GTPases: New insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 2008, 9, 690–701. [Google Scholar] [CrossRef] [PubMed]
- Tsou, P.S.; Haak, A.J.; Khanna, D.; Neubig, R.R. Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: Focus on RHO GTPase-regulated gene transcription. Am. J. Physiol. Cell Physiol. 2014, 307, 2–13. [Google Scholar] [CrossRef] [PubMed]
- Hartmann, S.; Ridley, A.J.; Lutz, S. The function of rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease. Front. Pharmacol. 2015, 6, 276. [Google Scholar] [CrossRef] [PubMed]
- Shi, J.; Zhang, Y.W.; Yang, Y.; Zhang, L.; Wei, L. ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice. J. Mol. Cell. Cardiol. 2010, 49, 819–828. [Google Scholar] [CrossRef]
- Haudek, S.B.; Gupta, D.; Dewald, O.; Schwartz, R.J.; Wei, L.; Trial, J.; Entman, M.L. Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation. Cardiovasc. Res. 2009, 83, 511–518. [Google Scholar] [CrossRef]
- Rikitake, Y.; Oyama, N.; Wang, C.Y.C.; Noma, K.; Satoh, M.; Kim, H.H.; Liao, J.K. Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/− haploinsufficient mice. Circulation 2005, 112, 2959–2965. [Google Scholar] [CrossRef]
- Hattori, T.; Shimokawa, H.; Higashi, M.; Hiroki, J.; Mukai, Y.; Tsutsui, H.; Kaibuchi, K.; Takeshita, A. Long-Term Inhibition of Rho-Kinase Suppresses Left Ventricular Remodeling after Myocardial Infarction in Mice. Circulation 2004, 109, 2234–2239. [Google Scholar] [CrossRef]
- Li, Q.; Xu, Y.; Li, X.; Guo, Y.; Liu, G. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: Role of TGF-β1-TAK1. Toxicol. Lett. 2012, 211, 91–97. [Google Scholar] [CrossRef]
- Mera, C.; Godoy, I.; Ramírez, R.; Moya, J.; Ocaranza, M.P.; Jalil, J.E. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat. Ther. Adv. Cardiovasc. Dis. 2016, 10, 4–20. [Google Scholar] [CrossRef]
- Luo, S.; Hieu, T.B.; Ma, F.; Yu, Y.; Cao, Z.; Wang, M.; Wu, W.; Mao, Y.; Rose, P.; Law, B.Y.K.; et al. ZYZ-168 alleviates cardiac fibrosis after myocardial infarction through inhibition of ERK1/2-dependent ROCK1 activation. Sci. Rep. 2017, 7, 43242. [Google Scholar] [CrossRef]
- Zhang, Y.M.; Bo, J.; Taffet, G.E.; Chang, J.; Shi, J.; Reddy, A.K.; Michael, L.H.; Schneider, M.D.; Entman, M.L.; Schwartz, R.J.; et al. Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. FASEB J. 2006, 20, 916–925. [Google Scholar] [CrossRef] [PubMed]
- Higashi, M.; Shimokawa, H.; Hattori, T.; Hiroki, J.; Mukai, Y.; Morikawa, K.; Ichiki, T.; Takahashi, S.; Takeshita, A. Long-Term Inhibition of Rho-Kinase Suppresses Angiotensin II-Induced Cardiovascular Hypertrophy in Rats In Vivo: Effect on Endothelial NAD(P)H Oxidase System. Circ. Res. 2003, 93, 767–775. [Google Scholar] [CrossRef] [PubMed]
- Okamoto, R.; Li, Y.; Noma, K.; Hiroi, Y.; Liu, P.Y.; Taniguchi, M.; Ito, M.; Liao, J.K. FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2. FASEB J. 2013, 27, 1439–1449. [Google Scholar] [CrossRef] [PubMed]
- Yang, X.; Li, Q.; Lin, X.; Ma, Y.; Yue, X.; Tao, Z.; Wang, F.; Mckeehan, W.L.; Wei, L.; Schwartz, R.J.; et al. Mechanism of fibrotic cardiomyopathy in mice expressing truncated Rho-associated coiled-coil protein kinase 1. FASEB J. 2012, 26, 2105–2116. [Google Scholar] [CrossRef] [PubMed]
- Shi, J.; Surma, M.; Yang, Y.; Wei, L. Disruption of both ROCK1 and ROCK2 genes in cardiomyocytes promotes autophagy and reduces cardiac fibrosis during aging. FASEB J. 2019, 33, 7348–7362. [Google Scholar] [CrossRef]
- Shimizu, T.; Narang, N.; Chen, P.; Yu, B.; Knapp, M.; Janardanan, J.; Blair, J.; Liao, J.K. Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction. JCI Insight 2017, 2, 93187. [Google Scholar] [CrossRef]
- Stellato, M.; Czepiel, M.; Distler, O.; Błyszczuk, P.; Kania, G. Identification and Isolation of Cardiac Fibroblasts From the Adult Mouse Heart Using Two-Color Flow Cytometry. Front. Cardiovasc. Med. 2019, 6, 105. [Google Scholar] [CrossRef]
- National Research Council. Guide for the Care and Use of Laboratory Animals; National Academies Press: Washington, DC, USA, 2011; ISBN 978-0-309-15400-0. [Google Scholar]
- Kania, G.; Blyszczuk, P.; Valaperti, A.; Dieterle, T.; Leimenstoll, B.; Dirnhofer, S.; Zulewski, H.; Eriksson, U. Prominin-1+/CD133+ bone marrow-derived heart-resident cells suppress experimental autoimmune myocarditis. Cardiovasc. Res. 2008, 80, 236–245. [Google Scholar] [CrossRef]
- Zarak-Crnkovic, M.; Kania, G.; Jaźwa-Kusior, A.; Czepiel, M.; Wijnen, W.J.; Czyż, J.; Müller-Edenborn, B.; Vdovenko, D.; Lindner, D.; Gil-Cruz, C.; et al. Heart non-specific effector CD4+ T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis. Basic Res. Cardiol. 2020, 115, 6. [Google Scholar] [CrossRef]
- Działo, E.; Rudnik, M.; Koning, R.I.; Czepiel, M.; Tkacz, K.; Baj-Krzyworzeka, M.; Distler, O.; Siedlar, M.; Kania, G.; Błyszczuk, P. WNT3a and WNT5a Transported by Exosomes Activate WNT Signaling Pathways in Human Cardiac Fibroblasts. Int. J. Mol. Sci. 2019, 20, 1436. [Google Scholar] [CrossRef]
- Moore-Morris, T.; Guimarães-Camboa, N.; Banerjee, I.; Zambon, A.C.; Kisseleva, T.; Velayoudon, A.; Stallcup, W.B.; Gu, Y.; Dalton, N.D.; Cedenilla, M.; et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J. Clin. Invest. 2014, 124, 2921–2934. [Google Scholar] [CrossRef] [PubMed]
- Shimizu, T.; Liao, J.K. Rho kinases and cardiac remodeling. Circ. J. 2016, 80, 1491–1498. [Google Scholar] [CrossRef] [PubMed]
- Surma, M.; Wei, L.; Shi, J. Rho kinase as a therapeutic target in cardiovascular disease. Future Cardiol. 2011, 7, 657–671. [Google Scholar] [CrossRef]
- Bao, W.; Hu, E.; Tao, L.; Boyce, R.; Mirabile, R.; Thudium, D.T.; Ma, X.L.; Willette, R.N.; Yue, T.L. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury. Cardiovasc. Res. 2004, 61, 548–558. [Google Scholar] [CrossRef]
- Ishimaru, K.; Ueno, H.; Kagitani, S.; Takabayashi, D.; Takata, M.; Inoue, H. Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte/macrophage infiltration in the heart of DOCA/salt hypertensive rats. J. Cardiovasc. Pharmacol. 2007, 50, 187–194. [Google Scholar] [CrossRef]
- Knipe, R.S.; Probst, C.K.; Lagares, D.; Franklin, A.; Spinney, J.J.; Brazee, P.L.; Grasberger, P.; Zhang, L.; Black, K.E.; Sakai, N.; et al. The rho kinase isoforms ROCK1 and ROCK2 each contribute to the development of experimental pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2018, 58, 471–481. [Google Scholar] [CrossRef]
- Zhou, L.; Liu, F.; Huang, X.R.; Liu, F.; Chen, H.; Chung, A.C.K.; Shi, J.; Wei, L.; Lan, H.Y.; Fu, P. Amelioration of albuminuria in ROCK1 knockout mice with streptozotocin-induced diabetic kidney disease. Am. J. Nephrol. 2011, 34, 468–475. [Google Scholar] [CrossRef]
- Vagnozzi, R.J.; Maillet, M.; Sargent, M.A.; Khalil, H.; Johansen, A.K.Z.; Schwanekamp, J.A.; York, A.J.; Huang, V.; Nahrendorf, M.; Sadayappan, S.; et al. An acute immune response underlies the benefit of cardiac stem cell therapy. Nature 2020, 577, 405–409. [Google Scholar] [CrossRef]
- Fu, P.; Liu, F.; Su, S.; Wang, W.; Huang, X.R.; Entman, M.L.; Schwartz, R.J.; Wei, L.; Lan, H.Y. Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice. J. Am. Soc. Nephrol. 2006, 17, 3105–3114. [Google Scholar] [CrossRef]
- Yu, O.M.; Brown, J.H. G Protein-Coupled Receptor and RhoA-Stimulated Transcriptional Responses: Links to Inflammation, Differentiation, and Cell Proliferation. Mol. Pharmacol. 2015, 88, 171–180. [Google Scholar] [CrossRef]
- Ohtsu, H.; Suzuki, H.; Nakashima, H.; Dhobale, S.; Frank, G.D.; Motley, E.D.; Eguchi, S. Angiotensin II signal transduction through small GTP-binding proteins: Mechanism and significance in vascular smooth muscle cells. Hypertens. (Dallas, Tex. 1979) 2006, 48, 534–540. [Google Scholar] [CrossRef] [PubMed]
- Blyszczuk, P.; Müller-Edenborn, B.; Valenta, T.; Osto, E.; Stellato, M.; Behnke, S.; Glatz, K.; Basler, K.; Lüscher, T.F.; Distler, O.; et al. Transforming growth factor-b-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis. Eur. Heart, J. 2017, 38, 1413–1425. [Google Scholar] [CrossRef] [PubMed]
- Lane, J.R.; Neumann, D.A.; Lafond-Walker, A.; Herskowitz, A.; Rose, N.R. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J. Immunol. 1993, 151, 1682–1690. [Google Scholar] [PubMed]
- Liu, Y.; Zhu, H.; Su, Z.; Sun, C.; Yin, J.; Yuan, H.; Sandoghchian, S.; Jiao, Z.; Wang, S.; Xu, H. IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway. Int. Immunol. 2012, 24, 605–612. [Google Scholar] [CrossRef]
- Chen, S.; Crawford, M.; Day, R.M.; Briones, V.R.; Leader, J.E.; Jose, P.A.; Lechleider, R.J. RhoA modulates Smad signaling during transforming growth factor-beta-induced smooth muscle differentiation. J. Biol. Chem. 2006, 281, 1765–1770. [Google Scholar] [CrossRef]
- Itoh, Y.; Kimoto, K.; Imaizumi, M.; Nakatsuka, K. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-β2 in human retinal pigment epithelial cells. Exp. Eye Res. 2007, 84, 464–472. [Google Scholar] [CrossRef]
- Manresa-Arraut, A.; Johansen, F.F.; Brakebusch, C.; Issazadeh-Navikas, S.; Hasseldam, H. RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis. Front. Immunol. 2018, 9, 1235. [Google Scholar] [CrossRef]
- Sun, X.; Minohara, M.; Kikuchi, H.; Ishizu, T.; Tanaka, M.; Piao, H.; Osoegawa, M.; Ohyagi, Y.; Shimokawa, H.; Kira, J.-I. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2006, 180, 126–134. [Google Scholar] [CrossRef]
- Biswas, P.S.; Gupta, S.; Chang, E.; Song, L.; Stirzaker, R.A.; Liao, J.K.; Bhagat, G.; Pernis, A.B. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J. Clin. Invest. 2010, 120, 3280–3295. [Google Scholar] [CrossRef]
- Dai, K.; Wang, Y.; Tai, S.; Ni, H.; Lian, H.; Yu, Y.; Liao, W.; Zheng, C.; Chen, Q.; Kuver, A.; et al. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis. Cardiovasc. Ther. 2018, 36, 12477. [Google Scholar] [CrossRef]
- Zhu, M.; Liu, P.-Y.; Kasahara, D.I.; Williams, A.S.; Verbout, N.G.; Halayko, A.J.; Fedulov, A.; Shoji, T.; Williams, E.S.; Noma, K.; et al. Role of Rho kinase isoforms in murine allergic airway responses. Eur. Respir. J. 2011, 38, 841–850. [Google Scholar] [CrossRef] [PubMed]
- Tönges, L. ROCKing regeneration: Rho kinase inhibition as molecular target for neurorestoration. Front. Mol. Neurosci. 2011, 4, 39. [Google Scholar] [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tkacz, K.; Rolski, F.; Czepiel, M.; Działo, E.; Siedlar, M.; Eriksson, U.; Kania, G.; Błyszczuk, P. Haploinsufficient Rock1+/− and Rock2+/− Mice Are Not Protected from Cardiac Inflammation and Postinflammatory Fibrosis in Experimental Autoimmune Myocarditis. Cells 2020, 9, 700. https://doi.org/10.3390/cells9030700
Tkacz K, Rolski F, Czepiel M, Działo E, Siedlar M, Eriksson U, Kania G, Błyszczuk P. Haploinsufficient Rock1+/− and Rock2+/− Mice Are Not Protected from Cardiac Inflammation and Postinflammatory Fibrosis in Experimental Autoimmune Myocarditis. Cells. 2020; 9(3):700. https://doi.org/10.3390/cells9030700
Chicago/Turabian StyleTkacz, Karolina, Filip Rolski, Marcin Czepiel, Edyta Działo, Maciej Siedlar, Urs Eriksson, Gabriela Kania, and Przemysław Błyszczuk. 2020. "Haploinsufficient Rock1+/− and Rock2+/− Mice Are Not Protected from Cardiac Inflammation and Postinflammatory Fibrosis in Experimental Autoimmune Myocarditis" Cells 9, no. 3: 700. https://doi.org/10.3390/cells9030700
APA StyleTkacz, K., Rolski, F., Czepiel, M., Działo, E., Siedlar, M., Eriksson, U., Kania, G., & Błyszczuk, P. (2020). Haploinsufficient Rock1+/− and Rock2+/− Mice Are Not Protected from Cardiac Inflammation and Postinflammatory Fibrosis in Experimental Autoimmune Myocarditis. Cells, 9(3), 700. https://doi.org/10.3390/cells9030700